Pharmaceuticals

The pharmaceutical industry has long been a highly profitable industry, showing steady growth with attractive yields. However, there has been increased pressure on the industry in recent years. Although profit margins for blockbuster drugs are still high, overall earnings are under enormous pressure due to many factors including regulatory and compliance issues, research and development expenses and the length of time it takes for drug approvals and licenses to be granted.

However, with the explosion of the emerging markets comes a regrettable side effect in that a significant percentage of people who are adopting westernised lifestyles will unfortunately acquire westernised illnesses. Already, China is experiencing a surge in diabetes cases and other such health-related issues. This, in turn, will benefit the drugs companies who will be well placed to treat the burgeoning numbers of patients.

These markets will safeguard the well-being of the larger companies but smaller operations could benefit too from investment into these locations. TGS has member firms in these emerging markets with industry-specific expertise and all are well placed to assist clients wishing to obtain new networking resources and professional assistance.

Our Sectors and Service

News

Howlader Maria & Co joins TGS Global Network

Howlader Maria & Co., Chartered Accountants is a professional firm in Bangladesh which is being formed to provi